Literature DB >> 2864302

A possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: interaction with oxygen free radicals.

P Del Soldato, M Campieri, C Brignola, G Bazzocchi, P Gionchetti, G A Lanfranchi, M Tamba.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2864302     DOI： 10.1016/0016-5085(85)90251-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  7 in total

Review 1.  Sulfasalazine. Multiplicity of action.

Authors:  T S Gaginella; R E Walsh
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

2.  Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine.

Authors:  Diana Couto; Daniela Ribeiro; Marisa Freitas; Ana Gomes; José L F C Lima; Eduarda Fernandes
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

3.  Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis.

Authors:  F Dallegri; L Ottonello; A Ballestrero; F Bogliolo; F Ferrando; F Patrone
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

4.  Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis.

Authors:  A Keshavarzian; J Haydek; R Zabihi; M Doria; M D'Astice; J R Sorenson
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

5.  Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.

Authors:  T P Mulder; H W Verspaget; A R Janssens; P A de Bruin; A S Peña; C B Lamers
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

Review 6.  Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

7.  Mechanism of action of 5-arninosalicylic acid.

Authors:  N A Punchard; S M Greenfield; R P Thompson
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.